{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:52:20Z","timestamp":1757620340344,"version":"3.44.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10787-025-01856-1","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T08:11:31Z","timestamp":1753776691000},"page":"4825-4840","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is ibuprofen associated with upper gastrointestinal bleeding? A systematic review and meta-analysis"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6407-8494","authenticated-orcid":false,"given":"Konstantinos","family":"Gkiouras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7626-5043","authenticated-orcid":false,"given":"Ioannis","family":"Myrogiannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3615-9745","authenticated-orcid":false,"given":"Dimitrios","family":"Kouvelas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"1856_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1185\/03007998309112390","volume":"8","author":"AK Admani","year":"1983","unstructured":"Admani AK, Verma S (1983) A study of sulindac versus ibuprofen in elderly patients with osteoarthritis. Curr Med Res Opin 8:315\u2013320. https:\/\/doi.org\/10.1185\/03007998309112390","journal-title":"Curr Med Res Opin"},{"key":"1856_CR2","unstructured":"Aragon TJ (2020) epitools: Epidemiology Tools. R package version 0.5-10.1"},{"key":"1856_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/EBMENTAL-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 22:153\u2013160. https:\/\/doi.org\/10.1136\/EBMENTAL-2019-300117","journal-title":"Evid Based Ment Health"},{"key":"1856_CR4","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ahj.2008.12.014","volume":"157","author":"MC Becker","year":"2009","unstructured":"Becker MC, Wang TH, Wisniewski L et al (2009) Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. Am Heart J 157:606\u2013612. https:\/\/doi.org\/10.1016\/j.ahj.2008.12.014","journal-title":"Am Heart J"},{"key":"1856_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","volume":"382","author":"N Bhala","year":"2013","unstructured":"Bhala N, Emberson J, Merhi A et al (2013) Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (London, England) 382:769\u2013779. https:\/\/doi.org\/10.1016\/S0140-6736(13)60900-9","journal-title":"Lancet (London, England)"},{"key":"1856_CR6","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/0016-5085(93)90667-2","volume":"104","author":"I Bjarnason","year":"1993","unstructured":"Bjarnason I, Hayllar J (1993) Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 104:1832\u20131847. https:\/\/doi.org\/10.1016\/0016-5085(93)90667-2","journal-title":"Gastroenterology"},{"key":"1856_CR7","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2165\/11633470-000000000-00000","volume":"35","author":"J Castellsague","year":"2012","unstructured":"Castellsague J, Riera-Guardia N, Calingaert B et al (2012) Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf 35:1127\u20131146. https:\/\/doi.org\/10.2165\/11633470-000000000-00000","journal-title":"Drug Saf"},{"key":"1856_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.surge.2009.11.007","volume":"8","author":"JK-K Chan","year":"2010","unstructured":"Chan JK-K, Sleat G, Sharma S et al (2010) Gastroprotection in trauma patients receiving non-steroidal anti-inflammatory drugs. Surgeon 8:206\u2013210. https:\/\/doi.org\/10.1016\/j.surge.2009.11.007","journal-title":"Surgeon"},{"key":"1856_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/AJE\/KWR301","volume":"175","author":"G Danaei","year":"2012","unstructured":"Danaei G, Tavakkoli M, Hern\u00e1n MA (2012) Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins. Am J Epidemiol 175:250. https:\/\/doi.org\/10.1093\/AJE\/KWR301","journal-title":"Am J Epidemiol"},{"key":"1856_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PMED.1002742","volume":"16","author":"OM Dekkers","year":"2019","unstructured":"Dekkers OM, Vandenbroucke JP, Cevallos M et al (2019) COSMOS-E: guidance on conducting systematic reviews and meta-analyses of observational studies of etiology. PLOS Med 16:e1002742. https:\/\/doi.org\/10.1371\/JOURNAL.PMED.1002742","journal-title":"PLOS Med"},{"key":"1856_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12874-022-01779-3","volume":"22","author":"M Felsch","year":"2022","unstructured":"Felsch M, Beckmann L, Bender R et al (2022) Performance of several types of beta-binomial models in comparison to standard approaches for meta-analyses with very few studies. BMC Med Res Methodol 22:319. https:\/\/doi.org\/10.1186\/s12874-022-01779-3","journal-title":"BMC Med Res Methodol"},{"key":"1856_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0895-4356(03)00255-5","volume":"57","author":"M Gallerani","year":"2004","unstructured":"Gallerani M, Simonato M, Manfredini R et al (2004) Risk of hospitalization for upper gastrointestinal tract bleeding. J Clin Epidemiol 57:103\u2013110. https:\/\/doi.org\/10.1016\/S0895-4356(03)00255-5","journal-title":"J Clin Epidemiol"},{"key":"1856_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00208-8","author":"LA Garc\u00eda Rodr\u00edguez","year":"1998","unstructured":"Garc\u00eda Rodr\u00edguez LA (1998) Variability in risk of gastrointestinal complications with different nonsteroidal anti-inflammatory drugs. Am J Med. https:\/\/doi.org\/10.1016\/S0002-9343(97)00208-8","journal-title":"Am J Med"},{"key":"1856_CR14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(94)91843-0","volume":"343","author":"L Garc\u00eda Rodr\u00edguez","year":"1994","unstructured":"Garc\u00eda Rodr\u00edguez L, Jick H (1994) Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet (London, England) 343:769\u2013772. https:\/\/doi.org\/10.1016\/S0140-6736(94)91843-0","journal-title":"Lancet (London, England)"},{"key":"1856_CR15","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/00001648-200109000-00018","volume":"12","author":"LA Garc\u00eda Rodr\u00edguez","year":"2001","unstructured":"Garc\u00eda Rodr\u00edguez LA, Hern\u00e1ndez-D\u00edaz S, Alberto Garc\u00eda Rodr\u00edguez L, Hern\u00e1ndez-D\u00edaz S (2001) Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology 12:570\u2013576. https:\/\/doi.org\/10.1097\/00001648-200109000-00018","journal-title":"Epidemiology"},{"key":"1856_CR16","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1111\/j.1572-0241.2000.02194.x","volume":"95","author":"JL Goldstein","year":"2000","unstructured":"Goldstein JL, Silverstein FE, Agrawal NM et al (2000) Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor. Am J Gastroenterol 95:1681\u20131690. https:\/\/doi.org\/10.1111\/j.1572-0241.2000.02194.x","journal-title":"Am J Gastroenterol"},{"key":"1856_CR17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1365-2036.2004.02118.x","volume":"20","author":"JL Goldstein","year":"2004","unstructured":"Goldstein JL, Eisen GM, Agrawal N et al (2004) Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib. Aliment Pharmacol Ther 20:527\u2013538. https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02118.x","journal-title":"Aliment Pharmacol Ther"},{"key":"1856_CR18","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1002\/SIM.2380","volume":"25","author":"RM Harbord","year":"2006","unstructured":"Harbord RM, Egger M, Sterne JAC (2006) A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25:3443\u20133457. https:\/\/doi.org\/10.1002\/SIM.2380","journal-title":"Stat Med"},{"key":"1856_CR19","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/1529-0131(200002)43:2<370::AID-ANR17>3.0.CO;2-D","volume":"43","author":"C Hawkey","year":"2000","unstructured":"Hawkey C, Laine L, Simon T et al (2000) Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy Multin. Arthritis Rheum 43:370\u2013377. https:\/\/doi.org\/10.1002\/1529-0131(200002)43:2%3c370::AID-ANR17%3e3.0.CO;2-D","journal-title":"Arthritis Rheum"},{"key":"1856_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-2036.2004.02026.x","volume":"20","author":"CJ Hawkey","year":"2004","unstructured":"Hawkey CJ, Farkouh M, Gitton X et al (2004) Therapeutic arthritis research and gastrointestinal event trial of lumiracoxib\u2014study design and patient demographics. Aliment Pharmacol Ther 20:51\u201363. https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02026.x","journal-title":"Aliment Pharmacol Ther"},{"key":"1856_CR21","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1136\/bmj.312.7046.1563","volume":"312","author":"D Henry","year":"1996","unstructured":"Henry D, Lim LL, Garcia Rodriguez LA et al (1996) Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 312:1563\u20131566. https:\/\/doi.org\/10.1136\/bmj.312.7046.1563","journal-title":"BMJ"},{"key":"1856_CR22","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1001\/ARCHINTE.160.14.2093","volume":"160","author":"S Hern\u00e1ndez-D\u00edaz","year":"2000","unstructured":"Hern\u00e1ndez-D\u00edaz S, Garc\u00eda Rodr\u00edguez LA (2000) Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding\/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 160:2093\u20132099. https:\/\/doi.org\/10.1001\/ARCHINTE.160.14.2093","journal-title":"Arch Intern Med"},{"key":"1856_CR23","unstructured":"Higgins JP, Thomas J, Chandler J, et al (eds) (2023) Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023)"},{"key":"1856_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0140-6736(02)07273-2","volume":"359","author":"JQ Huang","year":"2002","unstructured":"Huang JQ, Sridhar S, Hunt RH (2002) Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet (London, England) 359:14\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(02)07273-2","journal-title":"Lancet (London, England)"},{"key":"1856_CR25","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/SIM.7588","volume":"37","author":"D Jackson","year":"2018","unstructured":"Jackson D, Law M, Stijnen T et al (2018) A comparison of seven random-effects models for meta-analyses that estimate the summary odds ratio. Stat Med 37:1059\u20131085. https:\/\/doi.org\/10.1002\/SIM.7588","journal-title":"Stat Med"},{"key":"1856_CR26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/clpt.1993.55","volume":"53","author":"DW Kaufman","year":"1993","unstructured":"Kaufman DW, Kelly JP, Sheehan JE et al (1993) Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 53:485\u2013494. https:\/\/doi.org\/10.1038\/clpt.1993.55","journal-title":"Clin Pharmacol Ther"},{"key":"1856_CR27","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1111\/j.1572-0241.1999.01517.x","volume":"94","author":"DW Kaufman","year":"1999","unstructured":"Kaufman DW, Kelly JP, Wiholm BE et al (1999) The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol 94:3189\u20133196. https:\/\/doi.org\/10.1111\/j.1572-0241.1999.01517.x","journal-title":"Am J Gastroenterol"},{"key":"1856_CR28","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/SIM.6383","volume":"34","author":"O Kuss","year":"2015","unstructured":"Kuss O (2015) Statistical methods for meta-analyses including information from studies without any events-add nothing to nothing and succeed nevertheless. Stat Med 34:1097\u20131116. https:\/\/doi.org\/10.1002\/SIM.6383","journal-title":"Stat Med"},{"key":"1856_CR29","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/s0016-5085(99)70334-3","volume":"117","author":"L Laine","year":"1999","unstructured":"Laine L, Harper S, Simon T et al (1999) A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group. Gastroenterology 117:776\u2013783. https:\/\/doi.org\/10.1016\/s0016-5085(99)70334-3","journal-title":"Gastroenterology"},{"key":"1856_CR30","doi-asserted-by":"publisher","first-page":"A596","DOI":"10.1016\/s0016-5085(08)82966-6","volume":"120","author":"A Lanas","year":"2001","unstructured":"Lanas A (2001) Low frequency of upper gastrointestinal complications in the high risk patient taking low-dose aspirin or NSAIDs and omeprazole. Gastroenterology 120:A596. https:\/\/doi.org\/10.1016\/s0016-5085(08)82966-6","journal-title":"Gastroenterology"},{"key":"1856_CR31","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1080\/00365520310003967","volume":"38","author":"A Lanas","year":"2003","unstructured":"Lanas A, Rodrigo L, M\u00e1rquez JL et al (2003) Low frequency of upper gastrointestinal complications in a cohort of high-risk patients taking low-dose aspirin or NSAIDS and omeprazole. Scand J Gastroenterol 38:693\u2013700. https:\/\/doi.org\/10.1080\/00365520310003967","journal-title":"Scand J Gastroenterol"},{"key":"1856_CR32","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1136\/gut.2005.080754","volume":"55","author":"A Lanas","year":"2006","unstructured":"Lanas A, Garc\u00eda-Rodr\u00edguez LA, Arroyo MT et al (2006) Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut 55:1731\u20131738. https:\/\/doi.org\/10.1136\/gut.2005.080754","journal-title":"Gut"},{"key":"1856_CR33","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1572-0241.2006.01062.x","volume":"102","author":"A Lanas","year":"2007","unstructured":"Lanas A, Garc\u00eda-Rodr\u00edguez LA, Arroyo MT et al (2007) Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. Am J Gastroenterol 102:507\u2013515. https:\/\/doi.org\/10.1111\/j.1572-0241.2006.01062.x","journal-title":"Am J Gastroenterol"},{"key":"1856_CR34","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.cgh.2014.11.007","volume":"13","author":"\u00c1 Lanas","year":"2015","unstructured":"Lanas \u00c1, Carrera-Lasfuentes P, Arguedas Y et al (2015) Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants. Clin Gastroenterol Hepatol 13:906\u201312.e2. https:\/\/doi.org\/10.1016\/j.cgh.2014.11.007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1856_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.115","author":"FL Lanza","year":"2009","unstructured":"Lanza FL, Chan KL, Quigley EMM (2009) Guidelines for Prevention of NSAID-Related Ulcer Complications. Am J Gastroent 104(3):728\u2013738. https:\/\/doi.org\/10.1038\/ajg.2009.115","journal-title":"Am J Gastroent"},{"key":"1856_CR36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2165\/00002018-200427060-00005","volume":"27","author":"J-RR Laporte","year":"2004","unstructured":"Laporte J-RR, Ib\u00e1\u00f1ez L, Vidal X et al (2004) Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Saf 27:411\u2013420. https:\/\/doi.org\/10.2165\/00002018-200427060-00005","journal-title":"Drug Saf"},{"key":"1856_CR37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s100670200007","volume":"21","author":"JM Le Parc","year":"2002","unstructured":"Le Parc JM, Van Ganse E, Moore N et al (2002) Comparative tolerability of paracetamol, aspirin and ibuprofen for short-term analgesia in patients with musculoskeletal conditions: results in 4291 patients. Clin Rheumatol 21:28\u201331. https:\/\/doi.org\/10.1007\/s100670200007","journal-title":"Clin Rheumatol"},{"key":"1856_CR38","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1046\/J.1365-2125.2002.01636.X","volume":"54","author":"SC Lewis","year":"2002","unstructured":"Lewis SC, Langman MJS, Laporte JR et al (2002) Dose\u2013response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. Br J Clin Pharmacol 54:320. https:\/\/doi.org\/10.1046\/J.1365-2125.2002.01636.X","journal-title":"Br J Clin Pharmacol"},{"key":"1856_CR39","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/ART.27412","volume":"62","author":"EL Mass\u00f3 Gonz\u00e1lez","year":"2010","unstructured":"Mass\u00f3 Gonz\u00e1lez EL, Patrignani P, Tacconelli S, Garc\u00eda Rodr\u00edguez LA (2010) Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum 62:1592\u20131601. https:\/\/doi.org\/10.1002\/ART.27412","journal-title":"Arthritis Rheum"},{"key":"1856_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1600-0773.1994.tb01997.x","volume":"75","author":"M Matikainen","year":"1994","unstructured":"Matikainen M, Kangas E (1994) Relation of the use of analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) to upper gastrointestinal bleeding: a preliminary report of a finnish case-control prospective study. Pharmacol Toxicol 75:51\u201352. https:\/\/doi.org\/10.1111\/j.1600-0773.1994.tb01997.x","journal-title":"Pharmacol Toxicol"},{"key":"1856_CR41","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3109\/00365529609052001","volume":"31","author":"M Matikainen","year":"1996","unstructured":"Matikainen M, Kangas E (1996) Is there a relationship between the use of analgesics and non-steroidal anti-inflammatory drugs and acute upper gastrointestinal bleeding? A Finnish case-control prospective study. Scand J Gastroenterol 31:912\u2013916. https:\/\/doi.org\/10.3109\/00365529609052001","journal-title":"Scand J Gastroenterol"},{"key":"1856_CR42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1185\/03007995.2011.633990","volume":"28","author":"SL Michels","year":"2012","unstructured":"Michels SL, Collins J, Reynolds MW et al (2012) Over-the-counter ibuprofen and risk of gastrointestinal bleeding complications: a systematic literature review. Curr Med Res Opin 28:89\u201399. https:\/\/doi.org\/10.1185\/03007995.2011.633990","journal-title":"Curr Med Res Opin"},{"key":"1856_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2165\/00044011-199918020-00001\/METRICS","volume":"18","author":"N Moore","year":"1999","unstructured":"Moore N, Van Ganse E, Le Parc JM et al (1999) The PAIN study: Paracetamol, aspirin and ibuprofen new tolerability study. A large-scale, randomised clinical trial comparing the tolerability of aspirin, ibuprofen and paracetamol for short-term analgesia. Clin Drug Investig 18:89\u201398. https:\/\/doi.org\/10.2165\/00044011-199918020-00001\/METRICS","journal-title":"Clin Drug Investig"},{"key":"1856_CR44","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/(SICI)1099-1557(199912)8:7<501::AID-PDS454>3.0.CO;2-Y","volume":"8","author":"CI Neutel","year":"1999","unstructured":"Neutel CI, Maxwell CJ, Appel WC (1999) Differences between males and females in risk of NSAID-related severe gastrointestinal events. Pharmacoepidemiol Drug Saf 8:501\u2013507. https:\/\/doi.org\/10.1002\/(SICI)1099-1557(199912)8:7%3c501::AID-PDS454%3e3.0.CO;2-Y","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1856_CR45","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","volume":"375","author":"SE Nissen","year":"2016","unstructured":"Nissen SE, Yeomans ND, Solomon DH et al (2016) Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 375:2519\u20132529. https:\/\/doi.org\/10.1056\/NEJMoa1611593","journal-title":"N Engl J Med"},{"key":"1856_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/BMJMED-2022-000202","volume":"1","author":"J Orpen-Palmer","year":"2022","unstructured":"Orpen-Palmer J, Stanley AJ (2022) Update on the management of upper gastrointestinal bleeding. BMJ Med 1:e000202. https:\/\/doi.org\/10.1136\/BMJMED-2022-000202","journal-title":"BMJ Med"},{"key":"1856_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.N71","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https:\/\/doi.org\/10.1136\/BMJ.N71","journal-title":"BMJ"},{"key":"1856_CR48","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.amjmed.2003.10.040","volume":"116","author":"GV Papatheodoridis","year":"2004","unstructured":"Papatheodoridis GV, Papadelli D, Cholongitas E et al (2004) Effect of helicobacter pylori infection on the risk of upper gastrointestinal bleeding in users of nonsteroidal anti-inflammatory drugs. Am J Med 116:601\u2013605. https:\/\/doi.org\/10.1016\/j.amjmed.2003.10.040","journal-title":"Am J Med"},{"key":"1856_CR49","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1080\/00220973.2018.1561404","volume":"88","author":"M Rubio-Aparicio","year":"2020","unstructured":"Rubio-Aparicio M, L\u00f3pez-L\u00f3pez JA, Viechtbauer W et al (2020) Testing categorical moderators in mixed-effects meta-analysis in the presence of heteroscedasticity. J Exp Educ 88:288\u2013310. https:\/\/doi.org\/10.1080\/00220973.2018.1561404","journal-title":"J Exp Educ"},{"key":"1856_CR50","doi-asserted-by":"publisher","first-page":"501","DOI":"10.5694\/J.1326-5377.2006.TB00665.X","volume":"185","author":"D Schaffer","year":"2006","unstructured":"Schaffer D, Florin T, Eagle C et al (2006) Risk of serious NSAID-related gastrointestinal events during long-term exposure: a systematic review. Med J Aust 185:501\u2013506. https:\/\/doi.org\/10.5694\/J.1326-5377.2006.TB00665.X","journal-title":"Med J Aust"},{"key":"1856_CR51","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(04)16893-1","volume":"364","author":"TJ Schnitzer","year":"2004","unstructured":"Schnitzer TJ, Burmester GR, Mysler E et al (2004) Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Lancet (London, England) 364:665\u2013674. https:\/\/doi.org\/10.1016\/S0140-6736(04)16893-1","journal-title":"Lancet (London, England)"},{"key":"1856_CR52","unstructured":"Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, Oxman A (eds) (2013) GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations. The GRADE Working Group, 2013. Available from guidelinedevelopment.org\/handbook"},{"key":"1856_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4002","volume":"343","author":"JAC Sterne","year":"2011","unstructured":"Sterne JAC, Sutton AJ, Ioannidis JPA et al (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343:d4002. https:\/\/doi.org\/10.1136\/bmj.d4002","journal-title":"BMJ"},{"key":"1856_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JACC Sterne","year":"2019","unstructured":"Sterne JACC, Savovi\u0107 J, Page MMJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898","journal-title":"BMJ"},{"key":"1856_CR55","doi-asserted-by":"crossref","unstructured":"Strate LL, Singh P, Boylan MR, et al (2016) A prospective study of alcohol consumption and smoking and the risk of major gastrointestinal bleeding in men. PLoS One 11:","DOI":"10.1371\/journal.pone.0165278"},{"key":"1856_CR56","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1080\/00365520701478758","volume":"42","author":"M Udd","year":"2007","unstructured":"Udd M, Miettinen P, Palmu A et al (2007) Analysis of the risk factors and their combinations in acute gastroduodenal ulcer bleeding: a case-control study. Scand J Gastroenterol 42:1395\u20131403. https:\/\/doi.org\/10.1080\/00365520701478758","journal-title":"Scand J Gastroenterol"},{"key":"1856_CR57","doi-asserted-by":"publisher","first-page":"E58","DOI":"10.1097\/EDE.0000000000000733","volume":"28","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ (2017) On a square-root transformation of the odds ratio for a common outcome. Epidemiology 28:E58\u2013E60. https:\/\/doi.org\/10.1097\/EDE.0000000000000733","journal-title":"Epidemiology"},{"key":"1856_CR58","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/BIOM.13197","volume":"76","author":"TJ VanderWeele","year":"2020","unstructured":"VanderWeele TJ (2020) Optimal approximate conversions of odds ratios and hazard ratios to risk ratios. Biometrics 76:746\u2013752. https:\/\/doi.org\/10.1111\/BIOM.13197","journal-title":"Biometrics"},{"key":"1856_CR59","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1164","volume":"7","author":"AA Veroniki","year":"2016","unstructured":"Veroniki AA, Jackson D, Viechtbauer W et al (2016) Methods to estimate the between-study variance and its uncertainty in meta-analysis. Res Synth Methods 7:55\u201379. https:\/\/doi.org\/10.1002\/jrsm.1164","journal-title":"Res Synth Methods"},{"key":"1856_CR60","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/jrsm.1319","volume":"10","author":"AA Veroniki","year":"2019","unstructured":"Veroniki AA, Jackson D, Bender R et al (2019) Methods to calculate uncertainty in the estimated overall effect size from a random-effects meta-analysis. Res Synth Methods 10:23\u201343. https:\/\/doi.org\/10.1002\/jrsm.1319","journal-title":"Res Synth Methods"},{"key":"1856_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W (2010) Conducting meta-analyses in R with the metafor Package. J Stat Softw 36:1\u201348","journal-title":"J Stat Softw"},{"key":"1856_CR62","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/jrsm.11","volume":"1","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W, Cheung MW-L (2010) Outlier and influence diagnostics for meta-analysis. Res Synth Methods 1:112\u2013125. https:\/\/doi.org\/10.1002\/jrsm.11","journal-title":"Res Synth Methods"},{"key":"1856_CR63","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/JRSM.1460","volume":"11","author":"F Weber","year":"2020","unstructured":"Weber F, Knapp G, Ickstadt K et al (2020) Zero-cell corrections in random-effects meta-analyses. Res Synth Methods 11:913\u2013919. https:\/\/doi.org\/10.1002\/JRSM.1460","journal-title":"Res Synth Methods"},{"key":"1856_CR64","unstructured":"Witter J (1998) Celebrex capsules (celecoxib) NDA 20\u2013998. https:\/\/web.archive.org\/web\/20041117043941\/http:\/\/www.fda.gov\/cder\/foi\/adcomm\/98\/adac_12198-medrev1.pdf. Accessed 22 Sep 2024"},{"key":"1856_CR65","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/J.JCLINEPI.2021.02.012","volume":"135","author":"C Xu","year":"2021","unstructured":"Xu C, Furuya-Kanamori L, Zorzela L et al (2021) A proposed framework to guide evidence synthesis practice for meta-analysis with zero-events studies. J Clin Epidemiol 135:70\u201378. https:\/\/doi.org\/10.1016\/J.JCLINEPI.2021.02.012","journal-title":"J Clin Epidemiol"},{"key":"1856_CR66","doi-asserted-by":"publisher","first-page":"S166","DOI":"10.1016\/s0016-5085(17)30873-9","volume":"152","author":"ND Yeomans","year":"2017","unstructured":"Yeomans ND, Graham DY, Husni ME et al (2017) Gastrointestinal events in arthritis patients at increased cardiovascular risk treated chronically with celecoxib, naproxen or ibuprofen: the precision randomized controlled trial. Gastroenterology 152:S166. https:\/\/doi.org\/10.1016\/s0016-5085(17)30873-9","journal-title":"Gastroenterology"},{"key":"1856_CR67","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1111\/apt.14610","volume":"47","author":"ND Yeomans","year":"2018","unstructured":"Yeomans ND, Graham DY, Husni ME et al (2018) Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial. Aliment Pharmacol Ther 47:1453\u20131463. https:\/\/doi.org\/10.1111\/apt.14610","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01856-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01856-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01856-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:23:49Z","timestamp":1757312629000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01856-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1856"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01856-1","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"type":"print","value":"0925-4692"},{"type":"electronic","value":"1568-5608"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}